Slingshot members are tracking this event:
AbbVie (ABBV) Reports Data Phase 3 Data Evaluating Veliparib in Non-Small Cell Lung Cancer and Triple Negative Breast Cancer
Slingshot Insights Explained
Apr 19, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Veliparib, Non-small Cell Lung Cancer, Triple Negative Breast Cancer